Zuckerberg-backed Biohub coordinates $1.8 billion effort to build AI models of cell behavior
Zuckerberg-backed Biohub is coordinating $1.8 billion in funding and data to train AI models that could make drug research faster and more predictive.
Latest News and Analysis in Drug Development
Zuckerberg-backed Biohub is coordinating $1.8 billion in funding and data to train AI models that could make drug research faster and more predictive.
Insilico Medicine has launched a DDD Benchmark as a Service to test frontier AI and foundation models against real-world drug discovery and development tasks.
MIT researchers develop language model for codon optimization, boosting protein production including trastuzumab by 25-300%, published in PNAS.
MIT Professor Jim Collins leads groundbreaking research using generative AI to design programmable antibacterials targeting drug-resistant pathogens.